Variant #0000167055 (NC_000001.10:g.171076966G>A, NM_001002294.2:c.472G>A (FMO3))
| Chromosome |
1 |
| Allele |
Unknown |
| Affects function (as reported) |
Effect unknown |
| Affects function (by curator) |
Effect unknown |
| Classification method |
- |
| Clinical classification |
NA |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.171076966G>A |
| DNA change (hg38) |
g.171107825G>A |
| Published as |
- |
| ISCN |
- |
| DB-ID |
FMO3_000008 See all 27 reported entries |
| Variant remarks |
little/moderate substrate-dependent effect, results vary among labs, effect greater when present in cis with p.Glu308Gly: kcat/Km for methimazole reduced 16% (p.Glu158Lys) and 57% (p.Glu158Lys-Glu308Gly) (Allerston 2009). E158K shows 5-fold increased tamoxifen N-oxygenation (Krueger 2006). |
| Reference |
PubMed: Dolphin 1997, PubMed: Treacy 1998, PubMed: Zschocke 1999 |
| ClinVar ID |
- |
| dbSNP ID |
rs72549321 |
| Origin |
In vitro (cloned) |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
0.37494 View details |
| Owner |
Ornicha Prapapan |
| Database submission license |
No license selected |
| Created by |
Ornicha Prapapan |
| Date created |
2013-02-27 22:57:56 +01:00 (CET) |
| Date last edited |
2020-06-05 15:14:40 +02:00 (CEST) |

Variant on transcripts
|
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.
|